{
    "id": 13588,
    "fullName": "AXL A273V",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "AXL A273V lies within the fibronectin type-III domain 1 of the Axl protein (UniProt.org). A273V has been associated with resistance to EGFR inhibitors (Cancer Res 2018;78(13 Suppl): nr 4903), but has not been biochemically characterized and therefore, its effect on Axl protein function is unknown (PubMed, Oct 2019).",
            "references": [
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                },
                {
                    "id": 13525,
                    "pubMedId": null,
                    "title": "Abstract 4903: AXL inhibition overcomes erlotinib resistance in AXL-activated non-small cell lung cancer cells",
                    "url": "http://cancerres.aacrjournals.org/content/78/13_Supplement/4903"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 558,
        "geneSymbol": "AXL",
        "terms": [
            "AXL",
            "ARK",
            "JTK11",
            "Tyro7",
            "UFO"
        ]
    },
    "variant": "A273V",
    "createDate": "11/03/2015",
    "updateDate": "10/10/2019",
    "referenceTranscriptCoordinates": {
        "id": 162573,
        "transcript": "NM_021913",
        "gDna": "chr19:g.41237978C>T",
        "cDna": "c.818C>T",
        "protein": "p.A273V",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 18745,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, expression of AXL A273V in non-small cell lung cancer cells conferred resistance to Tarceva (erlotinib) in culture (Cancer Res 2018;78(13 Suppl): nr 4903).",
            "molecularProfile": {
                "id": 13775,
                "profileName": "AXL A273V"
            },
            "therapy": {
                "id": 4,
                "therapyName": "Erlotinib",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 13525,
                    "pubMedId": null,
                    "title": "Abstract 4903: AXL inhibition overcomes erlotinib resistance in AXL-activated non-small cell lung cancer cells",
                    "url": "http://cancerres.aacrjournals.org/content/78/13_Supplement/4903"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 13775,
            "profileName": "AXL A273V",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 162573,
            "transcript": "NM_021913",
            "gDna": "chr19:g.41237978C>T",
            "cDna": "c.818C>T",
            "protein": "p.A273V",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 162574,
            "transcript": "NM_001699",
            "gDna": "chr19:g.41237978C>T",
            "cDna": "c.818C>T",
            "protein": "p.A273V",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}